Cargando…
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.
A novel quantitative luminometric immunoassay (LIA) has been developed for the measurement of wild-type and mutant p53 protein in extracts from breast tumour tissue. The LIA was found to yield reliable estimates of p53 expression in cytosol samples routinely prepared for steroid receptor analysis as...
Autores principales: | Borg, A., Lennerstrand, J., Stenmark-Askmalm, M., Fernö, M., Brisfors, A., Ohrvik, A., Stål, O., Killander, D., Lane, D., Brundell, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033772/ https://www.ncbi.nlm.nih.gov/pubmed/7734292 |
Ejemplares similares
-
Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay
por: Lotter, Oliver, et al.
Publicado: (2010) -
p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group.
por: Stenmark-Askmalm, M., et al.
Publicado: (1995) -
Luminometric dosimetry of X-ray radiation by a zwitterionic uranium coordination polymer
por: Zheng, Zhaofa, et al.
Publicado: (2022) -
Evaluation of a Luminometric Cell Counting System in Context of Antimicrobial Photodynamic Inactivation
por: Lehnig, Moritz, et al.
Publicado: (2022) -
Multi-luminescent switching of metal-free organic phosphors for luminometric detection of organic solvents
por: Kwon, Min Sang, et al.
Publicado: (2016)